Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
New American Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
New American Therapeutics

New American Therapeutics

Series D

New American Therapeutics, Inc.: A specialty pharmaceutical firm focused on improving lives with cardiovascular solutions.

HQ
Roseland, NJ, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

New American Therapeutics, Inc. is a privately held specialty pharmaceutical company founded in Parsippany, New Jersey. The company's core mission is to improve patients' lives by acquiring, marketing, and developing pharmaceutical products in select therapeutic areas, with a particular focus on cardiovascular health. Their portfolio includes a lead product aimed at addressing cardiovascular conditions, reflecting their commitment to enhancing patient outcomes in this critical medical field.

Notable figures affiliated with New American Therapeutics include experienced leaders in the pharmaceutical industry, though specific names are not publicly highlighted. The company has successfully brought its lead cardiovascular product to market, demonstrating its capability to navigate the complexities of pharmaceutical development and commercialization. Overall, New American Therapeutics has made a significant impact by providing specialized treatments that address unmet medical needs in the cardiovascular sector.

New American Therapeutics - Similar Companies

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

Cortria logo

Cortria

Theracos logo

Theracos

theracos.com

Novita Therapeutics logo

Novita Therapeutics

Anexon logo

Anexon

Novatarg logo

Novatarg

novatarg.org

HDL Therapeutics logo

HDL Therapeutics

Therapyx logo

Therapyx

therapyxinc.com

Amerigen Pharmaceuticals logo

Amerigen Pharmaceuticals

amerigenpharma.com

TheraVasc logo

TheraVasc

Chase Therapeutics logo

Chase Therapeutics

Amneal Pharmaceuticals logo

Amneal Pharmaceuticals

amneal.com

Tenax Therapeutics logo

Tenax Therapeutics

tenaxthera.com

NanoPharmaceuticals logo

NanoPharmaceuticals

New American Therapeutics - Quick Facts

Who are New American Therapeutics' competitors?

Companies similar to New American Therapeutics include NeuroTherapeutics Pharma, Cardurion Pharmaceuticals, Cortria and Theracos.

When was New American Therapeutics founded?

New American Therapeutics was founded in 2010.

Where is New American Therapeutics' headquarters located?

New American Therapeutics' headquarters is located in Roseland, NJ, US.

When was New American Therapeutics' last funding round?

New American Therapeutics' most recent funding round was for $53M (USD) in September 2010.

How much has New American Therapeutics raised to-date?

As of Sep 1, 2010, New American Therapeutics has raised a total of $53M (USD).

How many employees does New American Therapeutics have?

New American Therapeutics has 5 employees as of Feb 4, 2024.

New American Therapeutics - Classification

Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Pharmaceutical
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified